Background/Aim: By definition, tumor cells do not pass the epithelial basement membrane in
pre-invasive lesions. However, recently, it was shown that hematogenous tumor cell …

Background: Detection of circulating tumor cells (CTCs) in the peripheral blood of patients
with primary breast cancer is associated with poor clinical outcome. Recent studies have …

Cancer is a risk factor for venous thromboembolism (VTE). Elevated plasma D-dimer and
fibrinogen levels are also risk factors for VTE. Furthermore, in patients with metastatic breast …

The prognosis of cancer patients is largely determined by the occurrence of distant
metastases. In patients with primary tumors, this relapse is mainly due to clinically occult …

CTCs are involved in tumor dissemination and are an independent prognostic factor in
primary and metastatic breast cancer patients. Dendritic cells (DCs) are the most efficient …

Purpose: Clinical significance of disseminated tumor cells (DTC) in bone marrow of early
breast cancer patients has been reported, but improvements in detection methods are …

Abstract Introduction Dendritic cells (DCs) are key antigen-presenting cells that play an
essential role in initiating and directing cellular and humoral immunity, including anti-tumor …

Patients with advanced cancer are known to have dysfunctions of the immune system.
Dendritic cells (DCs) are potent antigen-presenting cells that play a crucial role in antitumor …

The role of CD47 and PD-L1 expression on circulating tumor cells (CTCs) remains unclear,
and it is currently unknown whether their distribution varies between the blood and tumor …

Purpose The detection of disseminated tumor cells in the bone marrow (DTC-BM) of breast
cancer patients is an independent prognostic factor. In recent years, the focus of research …